Iowa SF233 amends the Right to Try Act to expand eligibility for investigational treatments and protect patients' heirs from treatment-related debts.
Iowa SF233 modifies the Right to Try Act by broadening the definition of "eligible patient" to include those with life-threatening or severely debilitating illnesses, in addition to those with terminal illnesses. The bill also extends the Act's application to individualized investigational treatments, which are tailored to a patient's genetic profile. It ensures that patients' heirs are not liable for debts incurred due to treatment, unless required by law.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.